Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maxillary bone preservation after tooth extraction with rhBMP-2 versus spontaneous healing
RBR-29nbjwCompleted
- Sponsor
- Universidade Guarulhos
- Start
- Aug 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of dibotermin alfa in conditions requiring dental extraction, gingival disease, carious lesion and 1 more (2 arms), sponsored by Universidade Guarulhos. Primary endpoint: Final alveolar bone volume after extraction. Started Aug 2014; status: completed.
02
Drugs
dibotermin alfa
03
Conditions
conditions requiring dental extractiongingival diseasecarious lesiondental fracture
Beyond the preview
Go deeper on RBR-29nbjw.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-29nbjw.